Levetiracetam LEV CAS 102767-28-2 API Factory USP EP

Description:

Nomen chemicum: Levetiracetam;LEV

CAS: 102767-28-2

Aspectus: Albus vel Fere Albus Crystal Pulvis

Intenta: 98.0%~ 102.0%

Tertia-generatio Antiepileptica medicamentis

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer Supple cum High puritate et stabulo Quality
Nomen chemicum: Levetiracetam
CAS: 102767-28-2
API USP/EP Standard, Productio Commercial
Tertia-generatio Antiepileptica medicamentis

Chemical Properties:

Nomen chemicum	Levetiracetam
Synonyma	LEV;(S)-2-(2-Oxo-1-pyrrolidinyl)butyramide;UCB-L059
CAS Number	102767-28-2
CATTUS Number	RF-API61
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C8H14N2O2
M. Pondus	170.21
Liquescens punctum	116.0-119.0℃
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba vel prope Crystalli pulveris
Lepidium sativum IR	Spectrum ab sample ablatum consistit in eo quod ex substantia referente obtinetur
Solutio specie	Patet non vehementius colorata quam BY6
Puritas Enantiomeric impuritas D	≤0.80%
Aqua	≤0.50%
Cinis sululated	≤0.10%
Metalla gravis	≤0.001%
Substantiae cognatae
immunditiam A	≤0.30%
Quis non specificatus immunditia	≤0.05%
Totalis non specificatae immunditias	≤0.10%
Totalis immunditias	≤0.40%
immunditia F	≤0.10%
RELICTUM Solvents
Benzene	≤2ppm
Dichloromethane	≤600ppm
Ethyl Acetate	≤5000ppm
Acetone	≤5000ppm
Assay	98.0%~ 102.0%
Test Standard	USP Latin;EP Standard
Consuetudinem	API Tertia generatio medicamentorum Antiepilepticum

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Levetiracetam (CAS: 102767-28-2), pilacetam derivatio, nova tertiae generationis antiepilepticae medicamentum ab US FDA anno 1999 probatum. initio adhibita est ad adiunctivam curationem partialium in adultorum invasiones.Anno 2005, Levetiracetam in tabulis oralibus et solutionibus tractatum adiunctivum probatum est de captionibus partialibus in pueris aetatis 4 annorum et supra.Praecipue adhibetur ad curationem additivam de captionibus partialibus in adultis et pueris supra 4 annos quinque, et tantum adhiberi potest ad captiones partiales et systemicas in adultis.Habet etiam quosdam effectus curativos in epilepsia myoclonica in adulescentia, epilepsia refractoria, absentia epilepsia in pueris et assidua epilepsia.